1-4 of 4
Fei Yan
Close
Sort by
Journal Articles

Metabolic profiling of myeloproliferative neoplasms reveals subtype specific metabolic traits

Kristina Kirschner, Kevin Rattigan, Vignir Helgason, Fei Yan
Journal: Blood
Blood (2022) 140 (Supplement 1): 12180.
https://doi.org/10.1182/blood-2022-166992
Published: 2022
Journal Articles

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/Rarα Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: In Vitro and In Vivo studies

Dijiong Wu, Keding Shao, MD, Qihao Zhou, MD, Jie Sun, Ziqi Wang, Fei Yan, Tingting Liu, Xiangping Wu, Baodong Ye, He Huang, MD PhD, Yuhong Zhou
Journal: Blood
Blood (2018) 132 (Supplement 1): 2646.
https://doi.org/10.1182/blood-2018-99-115699
Published: 2018
Journal Articles

A Phase II of Combination D aunorubicin and Cytarabine ( A ra-c) and Nilotinib ( TA signa) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression: Interim Results

Aref Al-Kali, MD, Raoul Tibes, MD PhD, Jeanne Palmer, MD, Hassan B Alkhateeb, MD, Pamela Atherton, Fei Yan, Shujun Liu, PhD, Rong He, MD, Shahrukh K. Hashmi, MD, Mark R Litzow, MD
Journal: Blood
Blood (2015) 126 (23): 3808.
https://doi.org/10.1182/blood.V126.23.3808.3808
Published: 2015
Journal Articles

AML1/ETO Cooperates with HIF1α to Promote Leukemogenesis through DNMT3a Transactivation

Xiaoning Gao, Fei Yan, PhD, Ji Lin, Li Gao, Xiaolin Lu, Shengcai Wei, Na Shen, Jiuxia Pang, Qiaoyang Ning, Ailing Deng, Yihan Xu, Jinlong Shi, Yonghui Li, Shujun Liu, PhD, Li Yu
Journal: Blood
Blood (2014) 124 (21): 3543.
https://doi.org/10.1182/blood.V124.21.3543.3543
Published: 2014